William R Larue's Net Worth

$55.1 Thousand

Estimate Recalculated Sep 8, 2024 07:34PM EST

Who is William R Larue?

William R Larue does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncternal Therapeutics, Inc., Conatus Pharmaceuticals Inc., Tracon Pharmaceuticals, Inc., CANCERVAX CORP, and CADENCE PHARMACEUTICALS INC.

SEC CIK

William R Larue's CIK is 0001265784

Past Insider Trading and Trends

2005 was William R Larue's most active year for acquiring shares with 5 total transactions. William R Larue's most active month to acquire stocks was the month of May. 2017 was William R Larue's most active year for disposing of shares, totalling 1 transactions. William R Larue's most active month to dispose stocks was the month of May. 2021 saw William R Larue paying a total of $25,001.90 for 42,045 shares, this is the most they've acquired in one year. In 2017 William R Larue cashed out on 2,500 shares for a total of $6,732.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47

Investor

William R Larue owns 16,144 units of Common Stock which is worth $72,163.68. From 2019 to 2024 William R Larue acquired a total of 16,144 shares in Oncternal Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 25
Form 4/A
—
0
—
—
0
Jun 11
Form 4/A
—
0
—
—
0
Sep 12
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Sep 12
Form 4
∞
26.17K
—
—
26.17K
Jun 7
Form 3
—
0
—
—
0
No matching records found

Conatus Pharmaceuticals Inc. (HSTO) Snapshot price: $0.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.13925

Investor

William R Larue owns 7,763 units of Common Stock which is worth $1,081.00. In the year 2015 William R Larue filed a total of 13 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 19
Form 4
-1.52%
-120.00
$1.26
-$150.64
7.76K
Dec 21
Form 4
—
0
—
—
0
Jun 14
Form 4
+489.16%
6.54K
$3.82
$25,001.90
7.88K
Jul 26
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 15
Form 4
-15.74%
-2.50K
$2.69
-$6,732.50
13.39K
Scheduled
Jun 2
Form 4
+89.41%
7.5K
—
—
15.89K
Jun 1
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found

CANCERVAX CORP No price found

Sr.VP and CFO

William R Larue owns 13,086 units of Common Stock. From 2003 to 2006 William R Larue acquired a total of 24,336 shares in CANCERVAX CORP.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 27
Form 4
∞
13.09K
—
—
13.09K
Mar 20
Form 4
—
0
—
—
0
Nov 3
Form 4
—
0
—
—
0
Jun 14
Form 4
∞
11.25K
—
—
11.25K
Feb 9
Form 4
—
0
—
—
0
Feb 27
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

CADENCE PHARMACEUTICALS INC No price found

SVP, CFO, Treasurer, Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found